Heart2Heart Canine Cardiology Learning Tool10 August 2015
Prevalence of heart disease
Many dogs seen in primary care veterinary practices have some form of heart disease, and the number escalates as dogs get older.
- Approximately 10% of all dogs have heart disease1
- The prevalence of mitral valve disease increases dramatically with age
- From 10% in younger (5–8 years) dogs2
- Up to 75% of dogs over 16 years of age3
© 2015 Boehringer Ingelheim Vetmedica GmbH.
Important safety information: VETMEDIN® should not be given in case of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. The safety of VETMEDIN® has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than atrioventricular valvular insufficiency or dilated cardiomyopathy. The safe use of VETMEDIN® has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches. Use only in dogs with clinical evidence of heart failure. The most common side effects reported in field studies were poor appetite, lethargy, diarrhea, dyspnea, azotemia, weakness, and ataxia. If side effects should occur, pet owners should contact their veterinarian. Please refer to the package insert for complete product information or visit www.vetmedin.com.
VETMEDIN® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH.
